SlideShare a Scribd company logo
1 of 47
Download to read offline
Induction of Labour
SOGC Clinical Practice Guideline, 2013
Aboubakr Elnashar
Benha University Hospital, EgyptAboubakr Elnashar
DEFINITIONS
Induction of labour
initiation of contractions in a pregnant woman who
is not in labour to help her achieve a vaginal birth
within 24 to 48 hs.
Successful induction
vaginal delivery within 24 to 48 hs of induction of
labour.
Elective induction
induction of labour in the absence of acceptable
fetal or maternal indications.
Cervical ripening
use of pharmacological or other means to soften,
efface, or dilate the cervix to increase the
likelihood of a vaginal delivery.
Aboubakr Elnashar
Tachysystole
> 5 C/10-min period averaged over 30 mins. This
is further subdivided into two categories, one with
and one without FHR changes.
Hypertonus
Excessive uterine contractions lasting > 120
seconds without FHR changes.
This term should be abandoned and has been
replaced by tachystole without FHR changes.
Hyperstimulation
Excessive uterine contractions (tachysystole or
hypertonus) with abnormal FHR changes.
This term should be abandoned and has been
replaced by tachystole with FHR changes.
Aboubakr Elnashar
INDICATI ONS
1. The indication for induction must be
documented, and discussion should include
reason for induction, method of induction, and
risks, including failure to achieve labour and
possible increased risk of CS. (III-B)
2. If induction of labour is unsuccessful, the
indication and method of induction should be
re-evaluated. (III-B)
3. Inductions should not be performed solely for
suspected fetal macrosomia. (III-D)
4. Inductions should not be performed solely
because of patient or care provider preference.
(III-D)
Aboubakr Elnashar
Induction is indicated when the risk of continuing
the pregnancy, for the mother or the fetus,
exceeds the risk associated with induced labour
and delivery.
Aboubakr Elnashar
I. High Priority
•• Preeclampsia ≥ 37 ws
•• Significant maternal disease not responding to
tt
•• Significant but stable APHge
•• Chorioamnionitis
•• Suspected fetal compromise
•• Term PLROM with maternal GBS colonization
Aboubakr Elnashar
II. Other Indications
•• Postdates (> 41+0 weeks) or post-term (> 42+0 weeks)
•• Uncomplicated twin pregnancy ≥ 38 weeks
•• Diabetes mellitus (glucose control may dictate urgency)
•• Alloimmune disease at or near term
•• IUGR
•• Oligohydramnios
•• Gestational hypertension ≥ 38 ws
•• IUFD
•• PROM at or near term, GBS negative
•• Logistical problems (history of rapid labour, distance to hospital)
•• IUFD in a prior pregnancy (Induction may be performed
to alleviate parental anxiety, but there is no known medical
or outcome advantage for mother or baby.)
Aboubakr Elnashar
Unacceptable Indications
•• Care provider or patient convenience
•• Suspected fetal macrosomia
(EFWt > 4000 gm) in a non-diabetic
{no reduction in the incidence of shoulder
dystocia but twice the risk of CS}.
Maternal request
IOL should not routinely be offered. However,
under exceptional circumstances
at or after 40 w (NICE, 2008).
Aboubakr Elnashar
Breech presentation
•IOL is not generally recommended.
•IOL:
1. ECV is unsuccessful, declined or contraindicated
2. Woman refused elective CS
3. Delivery is indicated
after discussing the associated risks with the woman.
Fetal growth restriction
If severe, IOL is not recommended. (NICE, 2008)
Aboubakr Elnashar
CONTRAINDICATI ONS
•• placenta or vasa previa or cord presentation
•• abnormal fetal lie or presentation
(e.g.transverse lie or footling breech)
•• prior classical or inverted T uterine incision
•• significant prior uterine surgery
(e.g. full thickness myomectomy)
•• active genital herpes
•• pelvic structural deformities
Aboubakr Elnashar
PRE-INDUCTION ASSESSMENT
5. Bishop score to determine the likelihood of
success and to select the appropriate method of
induction. (II-2A)
6. The Bishop score should be documented. (III-
B)
7. Induction of women with an unfavourable
cervix is associated with a higher failure rate in
nulliparous patients and a higher CS rate in
nulliparous and parous patients. (II-2A)
Aboubakr Elnashar
Factors influencing success rates of
induction
1. Bishop score,
2. Parity (prior vaginal delivery),
3. BMI,
4. Maternal age,
5. Estimated fetal weight
6. Diabetes.
Elevated BMI (> 40 kg/m2)
maternal age > 35 years
estimated fetal weight > 4 kg
diabetes mellitus have been shown to increase
the CS rate when labour is induced.
Aboubakr Elnashar
Aboubakr Elnashar
Burnett modified the scoring scheme (still in use
and still known as the Bishop score) so that each
variable was assigned a maximum value of 2 points
(for a maximum score of 10).
 Bishop score of > 6 is predictive of a successful
vaginal delivery.
Initial studies were limited to parous women, but
the score was later found also to be applicable to
nulliparous women
Of the Bishop score criteria, the most important is
cervical dilatation, followed by effacement, station,
and position, with the least important being
consistency.
Aboubakr Elnashar
Bishop scores found the highest risk of failed
induction and CS in both nulliparous and parous
women with scores of 0 to 3 versus those with a
Bishop score > 3.
Even women with a score of 4 to 6 had a
significantly higher risk of CS than those with
spontaneous labour.
Aboubakr Elnashar
US of the cervix
to predict successful labour induction: conflicting
results.
Rozenberg et al. reported that the Bishop score was
a better predictor of time interval from induction to
delivery.
Fetal fibronectin and TVS
have been shown to predict successful induction,
but neither have been shown to be superior to the
Bishop score.
Aboubakr Elnashar
PREVENTION OF INDUCTION
8. Every woman should ideally have an
ultrasound, preferably in the first trimester, to
confirm gestational age. (I-A)
9. Institutions should have quality assurance
programs and induction policies, including safety
tools such as checklists, to ensure that inductions
are performed only for acceptable indications. (II-
2B)
Routine antenatal ultrasound for confirmation of
expected date of delivery has been shown to
reduce induction rates for postdates (> 41+0
weeks) pregnancies after correction of dates
Aboubakr Elnashar
Routine sweeping (stripping) of membranes
promotes the onset of labour: decreases
induction rates.
{increase of local production of prostaglandins}.
insertion of a digit past the internal cervical os
followed by three circumferential passes of the
digit causing separation of the membranes from
the lower segment.
an adjunct to IOL rather than an actual method of
IOL.
Aboubakr Elnashar
When?
1. Prior to IOL
2. At 40& 41 w in nulliparous
3. At 41 w in parous
4. When a vag exam is carried out to assess the
cervix
5. labour does not start spontaneously.
Informed consent should therefore be obtained &
documented.
Aboubakr Elnashar
Massaging around the cervix in the vaginal
fornices
when the cervix was closed, a massage of the
cervical surface with the forefinger and middle
finger for 15 to 30 seconds .
may achieve a similar effect.
The woman should be informed of the
discomfort and pain and the possibility of bleeding
postprocedure before consent is obtained.
Aboubakr Elnashar
The effect of coitus on promoting labour is
unclear.
Reduction in the number of elective inductions
after the implementation of an induction
committee. The role of the committee was to
review each request and enforce the use of
proper indications for induction.
Aboubakr Elnashar
POST-DATE S INDUCTION
10. Women should be offered induction of labour
between 41+0 and 42+0 weeks as this intervention
may reduce perinatal mortality and meconium
aspiration syndrome without increasing the
Caesarean section rate. (I-A)
11. Women who chose to delay induction > 41+0
weeks should undergo twice-weekly assessment for
fetal well-being. (I-A)
Aboubakr Elnashar
OPTIONS FOR CERVICAL
RIPENING/INDUCTION: UNFAVOURABLE
CERVIX
I. Mechanical Options
Balloon devices (Foley catheter with and without
extra-amniotic saline infusion) that apply pressure
on the internal os of the cervix to stretch the lower
uterine segment and increase the release of local
PG.
Advantages:
Simplicity of use, potential for reversibility,
reduction in certain side effects such as excessive
uterine activity, and low cost
Aboubakr Elnashar
12. Intracervical Foley catheters are acceptable
agents (II-2B) that are safe both in the setting of a
vaginal birth after CS (I-B) and in the outpatient
setting. (II-2B)
13. Double lumen catheters may be considered a
second-line alternative. (II-2B)
Aboubakr Elnashar
Practice Points
•• There is an increased need for oxytocin when
Foley catheters are used.
•• In comparison with prostaglandins, Foley
catheters cause much less uterine tachysystole.
•• Foley catheters are not associated with
increased rates of maternal infection
(chorioamnionitis and endometritis) or
neonatal infection.
•• Use of Foley catheters does not reduce the rate
of CS from that of PG.
Aboubakr Elnashar
Balloon Devices: Foley Catheter
For a single balloon catheter, a no. 18 Foley is
introduced under sterile technique into the
intracervical canal past the internal os. The bulb is
then inflated with 30 to 60 cc of water. The catheter
is left in place until either it falls out spontaneously
or 24 hs have elapsed.
Some practitioners apply a small degree of
traction on the catheter by taping it to the inside of
the leg.
Contraindications:
Absolute: Low-lying placenta
Relative: antepartum hemorrhage, ROM, evidence
of lower tract genital infection.
Aboubakr Elnashar
II. PHARMACOLOGICAL OPTIONS
1. Prostaglandin E2
Prostaglandins E2 (cervical and vaginal) are
effective agents of cervical ripening and induction
of labour for an unfavourable cervix. (I)
Intravaginal prostaglandins E2 are preferred to
intracervical prostaglandins E2 because they
results in more timely vaginal deliveries. (I)
Aboubakr Elnashar
14. Prostaglandins E2 (cervical and vaginal) should
not be used in the setting of vaginal birth after
Caesarean section due to the increased risk of
uterine rupture. (II-2D)
15. Vaginal prostaglandins E2 may be considered
with ruptured membranes at term and can be used
in this setting. (I-A)
Aboubakr Elnashar
Practice Points
•• PGE2 reduce CS rates of women with an
unfavourable cervix and result in greater maternal
satisfaction.
•• Oxytocin can be started 30 mins after removal
of a dinpoprostone insert (Cervidil) and 6 hours
hours after gel (Prostin, Prepidil).
•• PGE2 in the setting of ruptured membranes had
more maternal but no more neonatal infections.
•• Care must be taken to avoid the insertion of the
higher dose of vaginal PGE2 (2 mg) into the
cervical canal.
•• Uterine tachysystole without FHR changes is
more common
Aboubakr Elnashar
2. Misoprotol:
•• Give 50 mcg orally with a drink of water (ensure
that it is swallowed quickly to avoid sublingual
absorption) or
give 25 mcg vaginally.
•• Repeat every 4 hours as long as contractions are
absent or non-painful.
•• Oxytocin can only be used 4 hours after the last
dose.
Aboubakr Elnashar
16. Misoprostol can be considered a safe and
effective agent for labour induction with intact
membranes and on an inpatient basis. (I-A)
17. Misoprostol should not be used in the setting
of vaginal birth after CS due to the increased risk
of uterine rupture. (II-3D)
18. Oxytocin should be started no earlier than 4
hours after the last dose of misoprostol. (III-B)
Aboubakr Elnashar
Practice Points
•• Misoprostol is more effective than PGE2 to
achieve vaginal delivery and results in less
epidural use but more uterine tachysystole.
•• PGE1 and PGE2 both reduce CS rates in an
unfavourable cervix.
•• The oral and vaginal routes have a similar
reduction of CS rates. The oral route needs more
oxytocin stimulation but the vaginal route will
have more tachysystole.
Aboubakr Elnashar
•• The lower vaginal dose (25 mcg) tends to need
more oxytocin stimulation and the higher vaginal
dose (≥ 50 mcg) tends to have more uterine
tachysystole.
•• All doses of misoprostol can cause uterine
tachysystole.
•• Fetal well-being is required before administration
of misoprostol. Electronic fetal monitoring should
be performed for 30 minutes after administration of
misoprostol and for 60 minutes after any
tachysystole.
Aboubakr Elnashar
OPTIONS FOR INDUCTION
WITH A FAVOURABLE CERVIX
1. Amniotomy
19. Amniotomy should be reserved for women with
a favourable cervix. Particular care should be given
in the case of unengaged presentation because
there is a risk of cord prolapse. (III-B)
20. After amniotomy, oxytocin should be
commenced early in order to establish labour. (III-
B)
Aboubakr Elnashar
Practice Point
•• Amniotomy creates a commitment to delivery
and should be performed when the indication for
induction is convincing and the reasons compelling
and documented.
Aboubakr Elnashar
2. Oxytocin
Example of low-dose protocol:
Initial dose of oxytocin..................................1 to 2 mU/min
Increase interval......................................................30 minutes
Dosage increment....................................................1 to 2 mU
Usual dose for good labour.........................8 to 12 mU/min
Maximum dose before reassessment.................30 mU/min
Example of high-dose protocol:
Initial dose of oxytocin..................................4 to 6 mU/min
Increase interval............................................15 to 30 minutes
Dosage increment...........................................4 to 6 mU/min
Usual dose for good labour.........................8 to 12 mU/min
Maximum dose before reassessment.................30 mU/min
Aboubakr Elnashar
Term PROM
21. oxytocin should be considered before expectant
management. (I-A)
22. Women positive for group B streptococcus
should be started on oxytocin as early as possible
after ruptured membranes in order to establish
labour within 24 hours. (III-B)
23. Both high- and low-dose oxytocin may be
considered within a hospital protocol. (III-B)
24. Because of the various concentrations, oxytocin
infusion rates should always be recorded in
mU/min rather than mL/hr. (III-L)
25. Oxytocin induction maybe considered in the
hospital setting of vaginal birth after CS. (II-3B)
Aboubakr Elnashar
Practice Points
•• With PROM, oxytocin stimulation is more
effective than expectant management to reduce
maternal infection and increase vaginal deliveries
within 24 hours, but it may increase CS rate.
•• In the setting of PROM, women preferred
oxytocin induction over expectant management.
Aboubakr Elnashar
Setting and timing
I. Outpatient:
If safety & support procedures are in place.
Should be audited continuously.
II. Inpatient :
In the morning {higher maternal satisfaction}.
Aboubakr Elnashar
Monitoring
1. Before:
•CTG
•Bishop score
Aboubakr Elnashar
2. During:
•CTG: When contractions begin
Once CTG is confirmed as normal: intermittent
auscultation
•Bishop score
-6 h after vag PGE2 tablet or gel, or 24 h after vag
PGE2 controlled-release pessary
-If a woman returns home after insertion of vag PGE2
tablet or gel, she should be asked to contact her
obstetrician:
when contractions begin,
if she has had no contractions after 6 h.
•Maternal & fetal monitoring
Once active labour is established
Aboubakr Elnashar
Pain relief
Inform woman:
•IOL is likely to be more painful than spontaneous
labour.
•The availability of pain relief options :
Simple analgesics
Epidural analgesia.
Support
labour in water .
Aboubakr Elnashar
Prevention & management of complications
I. Ut hyperstimulation
Tocolysis should be considered if ut hyperstimulation
occurs during induction of labour.
Tachysystole: >5 C/10 m for at least 20 m
Hypersystole/Hypertonus: C >2 m
Aboubakr Elnashar
II. Failed induction
Define:
labour not starting after one cycle of treatment
Management
Support.
CTG
Maternal condition
a. further attempt to induce labour or
b. CS
Aboubakr Elnashar
III. Cord prolapse
Prevention:
•Before induction, engagement of the presenting part
should be assessed.
•Palpate for umbilical cord presentation during the
preliminary vaginal examination
•Avoid dislodging the baby’s head.
•Amniotomy should be avoided if the baby’s head is
high.
Aboubakr Elnashar
IV. Uterine rupture
If uterine rupture is suspected during IOL: emergency
CS
Aboubakr Elnashar
ThankYou
Aboubakr Elnashar

More Related Content

What's hot

Management of Cervical Incompetence
Management of Cervical IncompetenceManagement of Cervical Incompetence
Management of Cervical IncompetenceKattey Kattey
 
Fibroid complicating pregnancy
Fibroid complicating pregnancyFibroid complicating pregnancy
Fibroid complicating pregnancyMilan Kharel
 
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Classification of caesarean section
Classification of caesarean sectionClassification of caesarean section
Classification of caesarean sectionlimgengyan
 
Induction of labour
Induction of labourInduction of labour
Induction of labourPOOJA KUMAR
 
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...Aboubakr Elnashar
 
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT sonal patel
 
1. prostaglandins in labour dr rabi
1. prostaglandins in labour dr rabi1. prostaglandins in labour dr rabi
1. prostaglandins in labour dr rabiRabi Satpathy
 
Misoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyMisoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyChimezie Obi
 
Previous cesarean section
Previous cesarean sectionPrevious cesarean section
Previous cesarean sectionobgymgmcri
 
Laparoscopic Tubal Recanalization Mob: 7289915430, www.drpradeepgarg
Laparoscopic Tubal Recanalization  Mob: 7289915430, www.drpradeepgargLaparoscopic Tubal Recanalization  Mob: 7289915430, www.drpradeepgarg
Laparoscopic Tubal Recanalization Mob: 7289915430, www.drpradeepgargPradeep Garg
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean sectionhemnathsubedii
 
CTG Interpretation .pptx
CTG Interpretation .pptxCTG Interpretation .pptx
CTG Interpretation .pptxWafaa Benjamin
 
Preterm labour
Preterm labourPreterm labour
Preterm labourPoly Begum
 

What's hot (20)

Management of Cervical Incompetence
Management of Cervical IncompetenceManagement of Cervical Incompetence
Management of Cervical Incompetence
 
Obstetric cholestasis
Obstetric cholestasisObstetric cholestasis
Obstetric cholestasis
 
Fibroid complicating pregnancy
Fibroid complicating pregnancyFibroid complicating pregnancy
Fibroid complicating pregnancy
 
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANIADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
ADHERENT PLACENTA DIAGNOSIS & MANAGEMENT BY DR SHASHWAT JANI
 
Classification of caesarean section
Classification of caesarean sectionClassification of caesarean section
Classification of caesarean section
 
Vbac
VbacVbac
Vbac
 
Induction of labour METHODS
Induction of labour  METHODS Induction of labour  METHODS
Induction of labour METHODS
 
Induction of labour
Induction of labourInduction of labour
Induction of labour
 
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...FIGO guidelines on  Placenta Accreta Spectrum Disorders:  Conservative manage...
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
 
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT
Ecv- External Cephalic Version- Define, Risk, procedure, step, benefits PPT
 
1. prostaglandins in labour dr rabi
1. prostaglandins in labour dr rabi1. prostaglandins in labour dr rabi
1. prostaglandins in labour dr rabi
 
Misoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyMisoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and Gynaecology
 
Previous cesarean section
Previous cesarean sectionPrevious cesarean section
Previous cesarean section
 
Management-of-Postterm-Pregnancy
Management-of-Postterm-PregnancyManagement-of-Postterm-Pregnancy
Management-of-Postterm-Pregnancy
 
Laparoscopic Tubal Recanalization Mob: 7289915430, www.drpradeepgarg
Laparoscopic Tubal Recanalization  Mob: 7289915430, www.drpradeepgargLaparoscopic Tubal Recanalization  Mob: 7289915430, www.drpradeepgarg
Laparoscopic Tubal Recanalization Mob: 7289915430, www.drpradeepgarg
 
Cervical stitches
Cervical stitchesCervical stitches
Cervical stitches
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean section
 
CTG Interpretation .pptx
CTG Interpretation .pptxCTG Interpretation .pptx
CTG Interpretation .pptx
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 

Viewers also liked

Induction of labor
Induction of laborInduction of labor
Induction of laborkr
 
Induction of labour (2)
Induction of labour (2)Induction of labour (2)
Induction of labour (2)drmcbansal
 
Induction of labour
Induction of labourInduction of labour
Induction of labourjoemax3
 
Contraception elligability criteria WHO: Aboubakr Elnashar
Contraception elligability criteria WHO: Aboubakr ElnasharContraception elligability criteria WHO: Aboubakr Elnashar
Contraception elligability criteria WHO: Aboubakr ElnasharAboubakr Elnashar
 
Monitorización fetal intraparto
Monitorización fetal intrapartoMonitorización fetal intraparto
Monitorización fetal intrapartoginejuan
 
induction of labor
induction of laborinduction of labor
induction of laborGedo 3enony
 
Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...Aboubakr Elnashar
 
Wiki.assessment of uterine contractions 2011
Wiki.assessment of uterine contractions 2011Wiki.assessment of uterine contractions 2011
Wiki.assessment of uterine contractions 2011cslonern
 
Broad ligament fibroid
Broad ligament fibroidBroad ligament fibroid
Broad ligament fibroidajay dhawle
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancyAboubakr Elnashar
 
Induction and augmentation of labour by dr jograjiya
Induction and augmentation of labour by dr jograjiyaInduction and augmentation of labour by dr jograjiya
Induction and augmentation of labour by dr jograjiyaJograjiya Gelabhai Raghubhai
 
Abnormal uterine contraction
Abnormal uterine contraction Abnormal uterine contraction
Abnormal uterine contraction Nirsuba Gurung
 
InduccióN Y ConduccióN
InduccióN Y ConduccióNInduccióN Y ConduccióN
InduccióN Y ConduccióNEslinta
 
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008Aboubakr Elnashar
 
Pelvis and pelvimetry
Pelvis and pelvimetryPelvis and pelvimetry
Pelvis and pelvimetryAyman Shehata
 
Cardiotocography (CTG)
Cardiotocography (CTG)Cardiotocography (CTG)
Cardiotocography (CTG)limgengyan
 

Viewers also liked (20)

Induction of labor
Induction of laborInduction of labor
Induction of labor
 
Induction of labour (2)
Induction of labour (2)Induction of labour (2)
Induction of labour (2)
 
Induction of labour
Induction of labourInduction of labour
Induction of labour
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
Contraception elligability criteria WHO: Aboubakr Elnashar
Contraception elligability criteria WHO: Aboubakr ElnasharContraception elligability criteria WHO: Aboubakr Elnashar
Contraception elligability criteria WHO: Aboubakr Elnashar
 
Monitorización fetal intraparto
Monitorización fetal intrapartoMonitorización fetal intraparto
Monitorización fetal intraparto
 
induction of labor
induction of laborinduction of labor
induction of labor
 
Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...
 
Wiki.assessment of uterine contractions 2011
Wiki.assessment of uterine contractions 2011Wiki.assessment of uterine contractions 2011
Wiki.assessment of uterine contractions 2011
 
Updated Obs and Gynae
Updated Obs and GynaeUpdated Obs and Gynae
Updated Obs and Gynae
 
Broad ligament fibroid
Broad ligament fibroidBroad ligament fibroid
Broad ligament fibroid
 
Pih
PihPih
Pih
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancy
 
Induction and augmentation of labour by dr jograjiya
Induction and augmentation of labour by dr jograjiyaInduction and augmentation of labour by dr jograjiya
Induction and augmentation of labour by dr jograjiya
 
Abnormal uterine contraction
Abnormal uterine contraction Abnormal uterine contraction
Abnormal uterine contraction
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 
InduccióN Y ConduccióN
InduccióN Y ConduccióNInduccióN Y ConduccióN
InduccióN Y ConduccióN
 
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
 
Pelvis and pelvimetry
Pelvis and pelvimetryPelvis and pelvimetry
Pelvis and pelvimetry
 
Cardiotocography (CTG)
Cardiotocography (CTG)Cardiotocography (CTG)
Cardiotocography (CTG)
 

Similar to Induction of labour2013

Optimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptxOptimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptxNiranjan Chavan
 
Induction of labor
Induction of laborInduction of labor
Induction of laborMansi Gupta
 
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdf
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdfAbnormal Labor [ Natnael Dechasa Gemeda pdf ].pdf
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdfDire Dawa University
 
ectopic pregnancy.pptx
ectopic pregnancy.pptxectopic pregnancy.pptx
ectopic pregnancy.pptxrochisha
 
Vaginal Birth after C Section (VBAC)
Vaginal Birth after C Section (VBAC)Vaginal Birth after C Section (VBAC)
Vaginal Birth after C Section (VBAC)Alicia Tan
 
Induction of labour
Induction of labourInduction of labour
Induction of labourjomanahadnan
 
Prior cesarean delivery (VBAC)
Prior cesarean delivery (VBAC)Prior cesarean delivery (VBAC)
Prior cesarean delivery (VBAC)nishma bajracharya
 
Induction and augmentation of labour
Induction and augmentation of labourInduction and augmentation of labour
Induction and augmentation of labourimanswati
 
Bleeding in early pregnancy
Bleeding in early pregnancy Bleeding in early pregnancy
Bleeding in early pregnancy Aboubakr Elnashar
 
A brief introduction to c section and how its done.
A brief introduction to c section and how its done.A brief introduction to c section and how its done.
A brief introduction to c section and how its done.JudeMusoke1
 
A brief introduction to c section and how its done.
A brief introduction to c section and how its done.A brief introduction to c section and how its done.
A brief introduction to c section and how its done.JudeMusoke1
 
Ectopic pregnancy by sarah aboelsoud
Ectopic pregnancy by sarah aboelsoudEctopic pregnancy by sarah aboelsoud
Ectopic pregnancy by sarah aboelsoudSarahAboelsoud1
 
6. induction of labour
6. induction of labour6. induction of labour
6. induction of labourAhmed Elbohoty
 
ECTOPIC PREGNANCY
ECTOPIC PREGNANCYECTOPIC PREGNANCY
ECTOPIC PREGNANCYArief Sobri
 

Similar to Induction of labour2013 (20)

Optimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptxOptimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptx
 
Postdate pregnancy
Postdate pregnancyPostdate pregnancy
Postdate pregnancy
 
Post dates and induction
Post dates and inductionPost dates and induction
Post dates and induction
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
Induction of lobour
Induction of lobourInduction of lobour
Induction of lobour
 
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdf
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdfAbnormal Labor [ Natnael Dechasa Gemeda pdf ].pdf
Abnormal Labor [ Natnael Dechasa Gemeda pdf ].pdf
 
ectopic pregnancy.pptx
ectopic pregnancy.pptxectopic pregnancy.pptx
ectopic pregnancy.pptx
 
Vaginal Birth after C Section (VBAC)
Vaginal Birth after C Section (VBAC)Vaginal Birth after C Section (VBAC)
Vaginal Birth after C Section (VBAC)
 
Bleeding during early pregnancy
Bleeding during early pregnancyBleeding during early pregnancy
Bleeding during early pregnancy
 
Induction of labour
Induction of labourInduction of labour
Induction of labour
 
Prior cesarean delivery (VBAC)
Prior cesarean delivery (VBAC)Prior cesarean delivery (VBAC)
Prior cesarean delivery (VBAC)
 
Induction OF labor
Induction OF laborInduction OF labor
Induction OF labor
 
Induction and augmentation of labour
Induction and augmentation of labourInduction and augmentation of labour
Induction and augmentation of labour
 
Bleeding in early pregnancy
Bleeding in early pregnancy Bleeding in early pregnancy
Bleeding in early pregnancy
 
A brief introduction to c section and how its done.
A brief introduction to c section and how its done.A brief introduction to c section and how its done.
A brief introduction to c section and how its done.
 
A brief introduction to c section and how its done.
A brief introduction to c section and how its done.A brief introduction to c section and how its done.
A brief introduction to c section and how its done.
 
Ectopic pregnancy by sarah aboelsoud
Ectopic pregnancy by sarah aboelsoudEctopic pregnancy by sarah aboelsoud
Ectopic pregnancy by sarah aboelsoud
 
6. induction of labour
6. induction of labour6. induction of labour
6. induction of labour
 
Abnormal Labour.pptx
Abnormal Labour.pptxAbnormal Labour.pptx
Abnormal Labour.pptx
 
ECTOPIC PREGNANCY
ECTOPIC PREGNANCYECTOPIC PREGNANCY
ECTOPIC PREGNANCY
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Recently uploaded

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 

Recently uploaded (20)

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 

Induction of labour2013

  • 1. Induction of Labour SOGC Clinical Practice Guideline, 2013 Aboubakr Elnashar Benha University Hospital, EgyptAboubakr Elnashar
  • 2. DEFINITIONS Induction of labour initiation of contractions in a pregnant woman who is not in labour to help her achieve a vaginal birth within 24 to 48 hs. Successful induction vaginal delivery within 24 to 48 hs of induction of labour. Elective induction induction of labour in the absence of acceptable fetal or maternal indications. Cervical ripening use of pharmacological or other means to soften, efface, or dilate the cervix to increase the likelihood of a vaginal delivery. Aboubakr Elnashar
  • 3. Tachysystole > 5 C/10-min period averaged over 30 mins. This is further subdivided into two categories, one with and one without FHR changes. Hypertonus Excessive uterine contractions lasting > 120 seconds without FHR changes. This term should be abandoned and has been replaced by tachystole without FHR changes. Hyperstimulation Excessive uterine contractions (tachysystole or hypertonus) with abnormal FHR changes. This term should be abandoned and has been replaced by tachystole with FHR changes. Aboubakr Elnashar
  • 4. INDICATI ONS 1. The indication for induction must be documented, and discussion should include reason for induction, method of induction, and risks, including failure to achieve labour and possible increased risk of CS. (III-B) 2. If induction of labour is unsuccessful, the indication and method of induction should be re-evaluated. (III-B) 3. Inductions should not be performed solely for suspected fetal macrosomia. (III-D) 4. Inductions should not be performed solely because of patient or care provider preference. (III-D) Aboubakr Elnashar
  • 5. Induction is indicated when the risk of continuing the pregnancy, for the mother or the fetus, exceeds the risk associated with induced labour and delivery. Aboubakr Elnashar
  • 6. I. High Priority •• Preeclampsia ≥ 37 ws •• Significant maternal disease not responding to tt •• Significant but stable APHge •• Chorioamnionitis •• Suspected fetal compromise •• Term PLROM with maternal GBS colonization Aboubakr Elnashar
  • 7. II. Other Indications •• Postdates (> 41+0 weeks) or post-term (> 42+0 weeks) •• Uncomplicated twin pregnancy ≥ 38 weeks •• Diabetes mellitus (glucose control may dictate urgency) •• Alloimmune disease at or near term •• IUGR •• Oligohydramnios •• Gestational hypertension ≥ 38 ws •• IUFD •• PROM at or near term, GBS negative •• Logistical problems (history of rapid labour, distance to hospital) •• IUFD in a prior pregnancy (Induction may be performed to alleviate parental anxiety, but there is no known medical or outcome advantage for mother or baby.) Aboubakr Elnashar
  • 8. Unacceptable Indications •• Care provider or patient convenience •• Suspected fetal macrosomia (EFWt > 4000 gm) in a non-diabetic {no reduction in the incidence of shoulder dystocia but twice the risk of CS}. Maternal request IOL should not routinely be offered. However, under exceptional circumstances at or after 40 w (NICE, 2008). Aboubakr Elnashar
  • 9. Breech presentation •IOL is not generally recommended. •IOL: 1. ECV is unsuccessful, declined or contraindicated 2. Woman refused elective CS 3. Delivery is indicated after discussing the associated risks with the woman. Fetal growth restriction If severe, IOL is not recommended. (NICE, 2008) Aboubakr Elnashar
  • 10. CONTRAINDICATI ONS •• placenta or vasa previa or cord presentation •• abnormal fetal lie or presentation (e.g.transverse lie or footling breech) •• prior classical or inverted T uterine incision •• significant prior uterine surgery (e.g. full thickness myomectomy) •• active genital herpes •• pelvic structural deformities Aboubakr Elnashar
  • 11. PRE-INDUCTION ASSESSMENT 5. Bishop score to determine the likelihood of success and to select the appropriate method of induction. (II-2A) 6. The Bishop score should be documented. (III- B) 7. Induction of women with an unfavourable cervix is associated with a higher failure rate in nulliparous patients and a higher CS rate in nulliparous and parous patients. (II-2A) Aboubakr Elnashar
  • 12. Factors influencing success rates of induction 1. Bishop score, 2. Parity (prior vaginal delivery), 3. BMI, 4. Maternal age, 5. Estimated fetal weight 6. Diabetes. Elevated BMI (> 40 kg/m2) maternal age > 35 years estimated fetal weight > 4 kg diabetes mellitus have been shown to increase the CS rate when labour is induced. Aboubakr Elnashar
  • 14. Burnett modified the scoring scheme (still in use and still known as the Bishop score) so that each variable was assigned a maximum value of 2 points (for a maximum score of 10).  Bishop score of > 6 is predictive of a successful vaginal delivery. Initial studies were limited to parous women, but the score was later found also to be applicable to nulliparous women Of the Bishop score criteria, the most important is cervical dilatation, followed by effacement, station, and position, with the least important being consistency. Aboubakr Elnashar
  • 15. Bishop scores found the highest risk of failed induction and CS in both nulliparous and parous women with scores of 0 to 3 versus those with a Bishop score > 3. Even women with a score of 4 to 6 had a significantly higher risk of CS than those with spontaneous labour. Aboubakr Elnashar
  • 16. US of the cervix to predict successful labour induction: conflicting results. Rozenberg et al. reported that the Bishop score was a better predictor of time interval from induction to delivery. Fetal fibronectin and TVS have been shown to predict successful induction, but neither have been shown to be superior to the Bishop score. Aboubakr Elnashar
  • 17. PREVENTION OF INDUCTION 8. Every woman should ideally have an ultrasound, preferably in the first trimester, to confirm gestational age. (I-A) 9. Institutions should have quality assurance programs and induction policies, including safety tools such as checklists, to ensure that inductions are performed only for acceptable indications. (II- 2B) Routine antenatal ultrasound for confirmation of expected date of delivery has been shown to reduce induction rates for postdates (> 41+0 weeks) pregnancies after correction of dates Aboubakr Elnashar
  • 18. Routine sweeping (stripping) of membranes promotes the onset of labour: decreases induction rates. {increase of local production of prostaglandins}. insertion of a digit past the internal cervical os followed by three circumferential passes of the digit causing separation of the membranes from the lower segment. an adjunct to IOL rather than an actual method of IOL. Aboubakr Elnashar
  • 19. When? 1. Prior to IOL 2. At 40& 41 w in nulliparous 3. At 41 w in parous 4. When a vag exam is carried out to assess the cervix 5. labour does not start spontaneously. Informed consent should therefore be obtained & documented. Aboubakr Elnashar
  • 20. Massaging around the cervix in the vaginal fornices when the cervix was closed, a massage of the cervical surface with the forefinger and middle finger for 15 to 30 seconds . may achieve a similar effect. The woman should be informed of the discomfort and pain and the possibility of bleeding postprocedure before consent is obtained. Aboubakr Elnashar
  • 21. The effect of coitus on promoting labour is unclear. Reduction in the number of elective inductions after the implementation of an induction committee. The role of the committee was to review each request and enforce the use of proper indications for induction. Aboubakr Elnashar
  • 22. POST-DATE S INDUCTION 10. Women should be offered induction of labour between 41+0 and 42+0 weeks as this intervention may reduce perinatal mortality and meconium aspiration syndrome without increasing the Caesarean section rate. (I-A) 11. Women who chose to delay induction > 41+0 weeks should undergo twice-weekly assessment for fetal well-being. (I-A) Aboubakr Elnashar
  • 23. OPTIONS FOR CERVICAL RIPENING/INDUCTION: UNFAVOURABLE CERVIX I. Mechanical Options Balloon devices (Foley catheter with and without extra-amniotic saline infusion) that apply pressure on the internal os of the cervix to stretch the lower uterine segment and increase the release of local PG. Advantages: Simplicity of use, potential for reversibility, reduction in certain side effects such as excessive uterine activity, and low cost Aboubakr Elnashar
  • 24. 12. Intracervical Foley catheters are acceptable agents (II-2B) that are safe both in the setting of a vaginal birth after CS (I-B) and in the outpatient setting. (II-2B) 13. Double lumen catheters may be considered a second-line alternative. (II-2B) Aboubakr Elnashar
  • 25. Practice Points •• There is an increased need for oxytocin when Foley catheters are used. •• In comparison with prostaglandins, Foley catheters cause much less uterine tachysystole. •• Foley catheters are not associated with increased rates of maternal infection (chorioamnionitis and endometritis) or neonatal infection. •• Use of Foley catheters does not reduce the rate of CS from that of PG. Aboubakr Elnashar
  • 26. Balloon Devices: Foley Catheter For a single balloon catheter, a no. 18 Foley is introduced under sterile technique into the intracervical canal past the internal os. The bulb is then inflated with 30 to 60 cc of water. The catheter is left in place until either it falls out spontaneously or 24 hs have elapsed. Some practitioners apply a small degree of traction on the catheter by taping it to the inside of the leg. Contraindications: Absolute: Low-lying placenta Relative: antepartum hemorrhage, ROM, evidence of lower tract genital infection. Aboubakr Elnashar
  • 27. II. PHARMACOLOGICAL OPTIONS 1. Prostaglandin E2 Prostaglandins E2 (cervical and vaginal) are effective agents of cervical ripening and induction of labour for an unfavourable cervix. (I) Intravaginal prostaglandins E2 are preferred to intracervical prostaglandins E2 because they results in more timely vaginal deliveries. (I) Aboubakr Elnashar
  • 28. 14. Prostaglandins E2 (cervical and vaginal) should not be used in the setting of vaginal birth after Caesarean section due to the increased risk of uterine rupture. (II-2D) 15. Vaginal prostaglandins E2 may be considered with ruptured membranes at term and can be used in this setting. (I-A) Aboubakr Elnashar
  • 29. Practice Points •• PGE2 reduce CS rates of women with an unfavourable cervix and result in greater maternal satisfaction. •• Oxytocin can be started 30 mins after removal of a dinpoprostone insert (Cervidil) and 6 hours hours after gel (Prostin, Prepidil). •• PGE2 in the setting of ruptured membranes had more maternal but no more neonatal infections. •• Care must be taken to avoid the insertion of the higher dose of vaginal PGE2 (2 mg) into the cervical canal. •• Uterine tachysystole without FHR changes is more common Aboubakr Elnashar
  • 30. 2. Misoprotol: •• Give 50 mcg orally with a drink of water (ensure that it is swallowed quickly to avoid sublingual absorption) or give 25 mcg vaginally. •• Repeat every 4 hours as long as contractions are absent or non-painful. •• Oxytocin can only be used 4 hours after the last dose. Aboubakr Elnashar
  • 31. 16. Misoprostol can be considered a safe and effective agent for labour induction with intact membranes and on an inpatient basis. (I-A) 17. Misoprostol should not be used in the setting of vaginal birth after CS due to the increased risk of uterine rupture. (II-3D) 18. Oxytocin should be started no earlier than 4 hours after the last dose of misoprostol. (III-B) Aboubakr Elnashar
  • 32. Practice Points •• Misoprostol is more effective than PGE2 to achieve vaginal delivery and results in less epidural use but more uterine tachysystole. •• PGE1 and PGE2 both reduce CS rates in an unfavourable cervix. •• The oral and vaginal routes have a similar reduction of CS rates. The oral route needs more oxytocin stimulation but the vaginal route will have more tachysystole. Aboubakr Elnashar
  • 33. •• The lower vaginal dose (25 mcg) tends to need more oxytocin stimulation and the higher vaginal dose (≥ 50 mcg) tends to have more uterine tachysystole. •• All doses of misoprostol can cause uterine tachysystole. •• Fetal well-being is required before administration of misoprostol. Electronic fetal monitoring should be performed for 30 minutes after administration of misoprostol and for 60 minutes after any tachysystole. Aboubakr Elnashar
  • 34. OPTIONS FOR INDUCTION WITH A FAVOURABLE CERVIX 1. Amniotomy 19. Amniotomy should be reserved for women with a favourable cervix. Particular care should be given in the case of unengaged presentation because there is a risk of cord prolapse. (III-B) 20. After amniotomy, oxytocin should be commenced early in order to establish labour. (III- B) Aboubakr Elnashar
  • 35. Practice Point •• Amniotomy creates a commitment to delivery and should be performed when the indication for induction is convincing and the reasons compelling and documented. Aboubakr Elnashar
  • 36. 2. Oxytocin Example of low-dose protocol: Initial dose of oxytocin..................................1 to 2 mU/min Increase interval......................................................30 minutes Dosage increment....................................................1 to 2 mU Usual dose for good labour.........................8 to 12 mU/min Maximum dose before reassessment.................30 mU/min Example of high-dose protocol: Initial dose of oxytocin..................................4 to 6 mU/min Increase interval............................................15 to 30 minutes Dosage increment...........................................4 to 6 mU/min Usual dose for good labour.........................8 to 12 mU/min Maximum dose before reassessment.................30 mU/min Aboubakr Elnashar
  • 37. Term PROM 21. oxytocin should be considered before expectant management. (I-A) 22. Women positive for group B streptococcus should be started on oxytocin as early as possible after ruptured membranes in order to establish labour within 24 hours. (III-B) 23. Both high- and low-dose oxytocin may be considered within a hospital protocol. (III-B) 24. Because of the various concentrations, oxytocin infusion rates should always be recorded in mU/min rather than mL/hr. (III-L) 25. Oxytocin induction maybe considered in the hospital setting of vaginal birth after CS. (II-3B) Aboubakr Elnashar
  • 38. Practice Points •• With PROM, oxytocin stimulation is more effective than expectant management to reduce maternal infection and increase vaginal deliveries within 24 hours, but it may increase CS rate. •• In the setting of PROM, women preferred oxytocin induction over expectant management. Aboubakr Elnashar
  • 39. Setting and timing I. Outpatient: If safety & support procedures are in place. Should be audited continuously. II. Inpatient : In the morning {higher maternal satisfaction}. Aboubakr Elnashar
  • 41. 2. During: •CTG: When contractions begin Once CTG is confirmed as normal: intermittent auscultation •Bishop score -6 h after vag PGE2 tablet or gel, or 24 h after vag PGE2 controlled-release pessary -If a woman returns home after insertion of vag PGE2 tablet or gel, she should be asked to contact her obstetrician: when contractions begin, if she has had no contractions after 6 h. •Maternal & fetal monitoring Once active labour is established Aboubakr Elnashar
  • 42. Pain relief Inform woman: •IOL is likely to be more painful than spontaneous labour. •The availability of pain relief options : Simple analgesics Epidural analgesia. Support labour in water . Aboubakr Elnashar
  • 43. Prevention & management of complications I. Ut hyperstimulation Tocolysis should be considered if ut hyperstimulation occurs during induction of labour. Tachysystole: >5 C/10 m for at least 20 m Hypersystole/Hypertonus: C >2 m Aboubakr Elnashar
  • 44. II. Failed induction Define: labour not starting after one cycle of treatment Management Support. CTG Maternal condition a. further attempt to induce labour or b. CS Aboubakr Elnashar
  • 45. III. Cord prolapse Prevention: •Before induction, engagement of the presenting part should be assessed. •Palpate for umbilical cord presentation during the preliminary vaginal examination •Avoid dislodging the baby’s head. •Amniotomy should be avoided if the baby’s head is high. Aboubakr Elnashar
  • 46. IV. Uterine rupture If uterine rupture is suspected during IOL: emergency CS Aboubakr Elnashar